Najat Khan, CEO, opened by stating that Recursion is at an important inflection point, harnessing its integrated AI-driven platform to "translate insights into evidence; evidence that this platform, ...

Shares of Recursion Pharmaceuticals (RXRX) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials, thanks primarily to a milestone ...

‘Tell Me Lies’ Creator Dives Into That Jaw-Dropping Finale and Explains Why the Show Is Ending: “We Couldn’t F*** It Up” Meaghan Oppenheimer unravels the chaotic season three and series finale that ...

After eight episodes of post-apocalypse insanity and plenty of irradiated creatures, Fallout wrapped up Season 2 with the season finale, “The Strip,” this week. Given that multiple characters are left ...

Learn how to implement the Adadelta optimization algorithm from scratch in Python. This tutorial explains the math behind Adadelta, why it was introduced as an improvement over Adagrad, and guides you ...

Prefer Newsweek on Google to see more of our trusted coverage when you search. Netflix’s latest Korean blockbuster The Great Flood has surged to the top of the platform’s global charts for nonglobal ...

Recursion Pharmaceuticals (NASDAQ: RXRX) experienced an 11% increase in stock price on Wednesday after JP Morgan raised its rating, noting the promising potential of its MEK inhibitor program. However ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...

Staff Writer Warning: This post contains spoilers for The Beast in Me. Five years after the finale of Homeland, Claire Danes has reunited with one of the creators of the Emmy-winning series for a new ...